https://www.alojapan.com/1253242/first-gad-treatment-filing-in-japan-viatris-effexor-shows-trial-success/ First GAD Treatment Filing in Japan: Viatris EFFEXOR Shows Trial Success #AnxietyDisorderTherapeutics #AnxietyMedicationApproval #DrugRegulatoryFiling #EFFEXOR #GADTreatmentJapan #GeneralizedAnxietyDisorder #Japan #JapanNews #JapanesePharmaceuticalMarket #news #Phase3ClinicalTrials #SNRIAntidepressant #VTRS Aiming to address a significant unmet need for which no other approved treatment option is available for generalized anxiety disorder pat…